Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck Cancer

2019 ◽  
Vol 41 (12) ◽  
pp. 2517-2528.e28 ◽  
Author(s):  
Carla Rognoni ◽  
Silvana Quaglini ◽  
Jan Baptist Vermorken ◽  
Loris De Cecco ◽  
Lisa Licitra ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Cost Effectiveness ◽  
Head And Neck ◽  
Neck Cancer ◽  
Patient Selection ◽  
Molecular Profile ◽  
Line Treatment ◽  
First Line ◽  
Selection For ◽  
First Line Treatment

scholarly journals Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer

PLoS ONE ◽  
2012 ◽  
Vol 7 (6) ◽  
pp. e38557 ◽  
Author(s):  
Malek B. Hannouf ◽  
Chander Sehgal ◽  
Jeffrey Q. Cao ◽  
Joseph D. Mocanu ◽  
Eric Winquist ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Cost Effectiveness ◽  
Head And Neck ◽  
Neck Cancer ◽  
Line Treatment ◽  
First Line ◽  
Platinum Based Chemotherapy ◽  
First Line Treatment

scholarly journals Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer

2018 ◽  
Vol 35 (3) ◽  
Author(s):  
Hannah Fuchs ◽  
Johannes Pammer ◽  
Christoph Minichsdorfer ◽  
Doris Posch ◽  
Gabriela Kornek ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

First-line treatment patterns for recurrent and/or metastatic head and neck cancer (R/M HNC) in Europe.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e16016-e16016
Author(s):  
M. C. Merlano ◽  
J. B. Vermorken ◽  
H. Wilke ◽  
J. Bourhis ◽  
R. Mesia ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Treatment Patterns ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Doris Posch ◽  
Hannah Fuchs ◽  
Gabriela Kornek ◽  
Anja Grah ◽  
Johannes Pammer ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer

2021 ◽  
Vol 41 (4) ◽  
pp. 2045-2051
Author(s):  
MOTOYUKI SUZUKI ◽  
YUKINORI TAKENAKA ◽  
TOSHIHIRO KISHIKAWA ◽  
YOSHIFUMI YAMAMOTO ◽  
ATSUSHI HANAMOTO ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

Oral Oncology ◽  
2016 ◽  
Vol 62 ◽  
pp. 54-59 ◽  
Author(s):  
Elvira del Barco Morillo ◽  
Ricard Mesía ◽  
Juan Carlos Adansa Klain ◽  
Silvia Vázquez Fernández ◽  
Joaquina Martínez-Galán ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Surgical rescue for persistent head and neck cancer after first-line treatment

2020 ◽  
Vol 277 (5) ◽  
pp. 1437-1448 ◽  
Author(s):  
Teresa Bernadette Steinbichler ◽  
L. Golm ◽  
D. Dejaco ◽  
D. Riedl ◽  
B. Kofler ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document